Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationAnemia, AplasticTransplantation ConditioningTransplantation, AutologousLeukemiaSurvival AnalysisHematopoietic Stem Cell TransplantationGraft RejectionHematopoietic Stem CellsBone and BonesHLA AntigensLeukocyte TransfusionRadiation ChimeraTransplantation, IsogeneicLiver TransplantationGraft Enhancement, ImmunologicLiving DonorsTransplantation ToleranceImmunosuppressionKidney TransplantationBone Marrow PurgingMice, Inbred C57BLBlood DonorsRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsBone Marrow DiseasesBusulfanTreatment OutcomeTime FactorsSkin TransplantationTransplantation ImmunologyLymphocyte DepletionGraft vs Host ReactionT-LymphocytesChimerismTissue and Organ ProcurementAcute DiseaseBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideHematopoiesisHeart TransplantationActuarial AnalysisHematologic NeoplasmsBone Marrow NeoplasmsCombined Modality TherapyLeukemia, Myeloid, AcuteRemission InductionChimeraLymphocyte Culture Test, MixedDisease-Free SurvivalRetrospective StudiesMice, Inbred BALB CLeukemia, MyeloidHepatic Veno-Occlusive DiseaseColony-Forming Units AssayBone RemodelingStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionCord Blood Stem Cell TransplantationMyelodysplastic SyndromesSevere Combined ImmunodeficiencySurvival RateCell DifferentiationFlow CytometryHematologic DiseasesLung TransplantationCyclosporineMice, Inbred C3HSpleenPancytopeniaImmune ToleranceBone DensityOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedLeukocyte CountGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectFollow-Up StudiesCarmustineCytomegalovirus InfectionsCytarabineMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Bone Resorption